Publications
203
Citations
6,155
Est. group size
—
Recurring co-author estimate
Active years
45
Publishing since 1982
Typically publishes in teams of ~12 · 10% small-team papers (≤3 authors) · across 56 venues
- Medical thoracoscopy with talc poudrage and indwelling pleural catheter insertion versus medical thoracoscopy with talc poudrage alone for patients with symptomatic malignant pleural effusion (TACTIC): a randomised, controlled phase 3 trial
The Lancet Respiratory Medicine · 2026
- British Thoracic Society Quality Standard for Pleural Disease
BMJ Open Respiratory Research · 2026
- Myo‐Guide: A Machine Learning‐Based Web Application for Neuromuscular Disease Diagnosis With MRI
Journal of Cachexia Sarcopenia and Muscle · 2025
- An Indirect Treatment Comparison of Avalglucosidase Alfa versus Cipaglucosidase Alfa Plus Miglustat in Patients with Late-Onset Pompe Disease
Advances in Therapy · 2025
- Reaching consensus on comprehensive and achievable monitoring for adults with late-onset Pompe disease in the UK
Molecular Genetics and Metabolism · 2025
- Post-baseline outcomes of the UK Early Access to Medicines Scheme registry for cipaglucosidase alfa plus miglustat in late-onset Pompe disease
Molecular Genetics and Metabolism · 2025
- Miglustat: A first-in-class enzyme stabilizer for late-onset Pompe disease
Molecular Genetics and Metabolism · 2025
- Miglustat: A First-In-Class Enzyme Stabilizer for Late-Onset Pompe Disease (P10-2.012)
Neurology · 2025
- Long-Term Neuromuscular, Cardiac and Liver Outcomes in an Adult Man Affected with Chanarin-Dorfman Syndrome
SSRN Electronic Journal · 2025
- Pneumothorax and pneumomediastinum
European Respiratory Society eBooks · 2025
- 186 Lung-on-a-chip approach to investigate calcium signaling dysregulation in cystic fibrosis
Journal of Cystic Fibrosis · 2025
- 76P208-week efficacy and safety of cipaglucosidase alfa plus miglustat in patients with late-onset Pompe disease treated from PROPEL baseline: muscle function and biomarkers
Neuromuscular Disorders · 2025
- 198PThe UK facioscapulohumeral muscular dystrophy patient registry: a powerful tool to support clinical research and patient voice in the translational research pathway
Neuromuscular Disorders · 2025
- Long-term neuromuscular, cardiac and liver outcomes in an adult man affected with Chanarin-Dorfman syndrome
Molecular Genetics and Metabolism Reports · 2025
- Start, switch and stop (triple‐S) criteria for enzyme replacement therapy of late‐onset Pompe disease: European Pompe Consortium recommendation update 2024
European Journal of Neurology · 2024
- Molecular Genetics and Metabolism×21
- Neuromuscular Disorders×13
- Lara D. Veeken×6
- Neurology×6
- BMJ Open Respiratory Research×4
- Emily de los Reyes
Medicine · The Ohio State University
- Michael Beck
Medicine · The Ohio State University
- Molly McPheron
Medicine · Indiana University
- Yoonjin Cho
Medicine · University of Michigan
- Mari Mori
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile